Publicly-Held Company
Corporate Taxpayer's ID No. 60.746.948/0001-12
COMMUNICATION ON RELATED-PARTY TRANSACTIONS
Medical Services
Banco Bradesco S.A. ("Bradesco" or "Company") informs its shareholders and the market in general, in accordance with Article 30 and Exhibit 30-XXXVI of Securities and Exchange Commission ("CVM") Instruction No. 480/09 and Related-Party Transactions Policy of the Company ("Internal Policy") that, on this date, the Operational Agreement initiated in April of this year between Fleury S.A. ("Fleury") and Bradesco Saúde S.A. ("Bradesco Saúde"), Bradesco´s wholly-owned subsidiary, with the purpose of carry out COVID-19 tests in Bradesco Organization´s employees and their dependents who are beneficiaries of Bradesco Saúde ("Transaction"), was finalized.
The information referring to the Transaction, provided in the aforementioned CVM Instruction, are listed in the chart below:
Transaction | ||||||||
Related-Party´s Name | Fleury | |||||||
Bradesco holds, direct and indirectly, 100% of the capital of | ||||||||
Relation between the Related- | Bradseg Participações S.A. ("Bradseg") and Bradesco Saúde. | |||||||
Party and the Company | Bradseg holds around 22% of the shares issued by Fleury. | |||||||
Medical Services provided by Fleury, in the area of diagnostics | ||||||||
Transaction´s Subject | tests and clinical analyses relating to the performance of | |||||||
COVID-19 tests, to Bradesco Organization´s employees and | ||||||||
their dependents, who are beneficiaries of Bradesco Saúde. | ||||||||
Signature Date: 12.30.2020. | ||||||||
Duration: In effect until 04.16.2021 and may be extended by | ||||||||
prior agreement between the parties. The Operational | ||||||||
Agreement will start on this date, with its legal effects | ||||||||
Main Terms and Conditions | retroactively to 04.17.2020. | |||||||
Total Amount: R$ 63,000,000.00 (sixty three million reais). | ||||||||
Method of payment: monthly instalment, according to the | ||||||||
quantity and type of tests actually performed. | ||||||||
If, when, how and to what extend | ||||||||
the | counterparty | in | the | |||||
transaction, | its | partners | or | Not applicable. | ||||
managers | participated | in | the | |||||
process | ||||||||
Detailed | justification | of | the | The Company´s Management understands that the | ||||
reasons | why | the | issuer's | Transaction observed commutative conditions and provides | ||||
Management | considers | that | the | for adequate compensatory payment, since was carried out in | ||||
Transaction | observed | the best interest of the Company, observing Market Conditions | ||||||
commutative | conditions | or | (according to the Company's Internal Policy), good governance | |||||
provides | for | adequate | practices, conduct, ethics and transparency and no Conflicts of | |||||
compensatory payment | Interest (according to the Company's Internal Policy). |
The documents referring to the Transaction are filed at the Company´s
headquarters.
Cidade de Deus, Osasco, SP, December 30, 2020.
Banco Bradesco S.A.
Leandro de Miranda Araujo
Deputy Executive Officer and
Investor Relations Officer
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Banco Bradesco SA published this content on 30 December 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 December 2020 23:26:02 UTC